BRANFORD, Conn. May 31, 2007 454 Life Sciences Corporation, in collaboration with scientists at the Human Genome Sequencing Center, Baylor College of Medicine, announced today in Houston, Texas, the completion of a project to sequence the genome of James D. Watson, Ph.D., co-discoverer of the double-helix structure of DNA. The mapping of Dr. Watsons genome was completed using the Genome Sequencer FLX system and marks the first individual genome to be sequenced for less than $1 million.
When we began the Human Genome Project, we anticipated it would take 15 years to sequence the 3 billion base pairs and identify all the genes, said Richard Gibbs, Ph.D. , director, Human Genome Sequencing Center, Baylor College of Medicine. We completed it in 13 years in 2003 coinciding with the 50th anniversary of the publication of the work of Watson and Dr. Francis Crick that described the double helix. Today, we give James Watson a DVD containing his personal genome a project completed in only two months. It demonstrates how far sequencing technology has come in a short time.
Christopher McLeod, president and CEO of 454 Life Sciences, added: The sequencing of Dr. Watsons genome validates the approach taken by 454 Life Sciences in developing a technology to make the sequencing of individual human genomes quick and affordable. As we take another step on the path toward the X-Prize and reducing the cost of human genome sequencing to $10,000, we hope to enable a new era of medicine that is tailored to a patient's unique genetic profile.
Michael Egholm, Ph.D., vice president of research and development of 454 Life Sciences, said: The sequencing of Dr. Watsons genome has been done on production Genome Sequencer FLX systems, where we could take advantage of the instruments high quality data and long read lengths. Using the unbiased 454 Sequencing technology, we obtained a near complete picture of Dr. Watson's genome and were able to identify mis
Contact: Tony Russo
Russo Partners, LLC